Filter
1234
Text search:
human
pharmaceutical
products
Featured
Recommendations
118
New Publications
332
Language
Document type
No document type
595
Studies & Reports
263
Guidelines
192
Manuals
72
Strategic & Response Plan
69
Training Material
15
Fact sheets
13
Situation Updates
8
Resource Platforms
4
Brochures
2
Infographics
1
Countries / Regions
Kenya
60
Global
51
Ethiopia
40
India
37
Nigeria
27
South Africa
27
Sierra Leone
26
Western and Central Europe
26
Uganda
24
Liberia
23
Rwanda
22
Ghana
21
Namibia
20
Zambia
18
Tanzania
18
Ukraine
17
Philippines
15
Africa
15
Nepal
14
Bangladesh
12
Malawi
12
Latin America and the Carribbean
12
Eastern Europe
12
Zimbabwe
11
Indonesia
11
Lesotho
9
Myanmar / Burma
9
Eswatini/ Swaziland
8
West and Central Africa
7
Burkina Faso
6
Syria
6
Botswana
6
Eastern Europe and Central Asia
6
Asia
6
Cambodia
5
East and Southern Africa
5
Senegal
4
Congo, Democratic Republic of
4
Cameroon
4
Haiti
4
South–East Asia Region
4
Guinea
3
Jordan
3
Thailand
3
Mozambique
3
Sudan
3
North Macedonia
3
Venezuela
3
Russia
3
North America
3
Mali
2
USA
2
Pakistan
2
South Sudan
2
China
2
Benin
2
Central African Republic
2
Brazil
2
Middle East and North Africa
2
Fiji
2
Albania
2
Laos
2
Moldova
2
Kyrgyzstan
2
Georgia
2
Vietnam
2
Jamaica
2
Saudi Arabia
1
Niger
1
Somalia
1
Iraq
1
Afghanistan
1
Germany
1
Lebanon
1
Egypt
1
Papua New Guinea
1
Serbia
1
Libya
1
Madagascar
1
Western Pacific Region
1
Armenia
1
Timor Leste/ East Timor
1
Tajikistan
1
Bulgaria
1
Iran
1
Uzbekistan
1
Australia
1
Kazakhstan
1
Gabon
1
Denmark
1
Maldives
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
504
Clinical Guidelines
89
Key Resources
64
Public Health
59
Women & Child Health
33
Pharmacy & Technologies
24
Capacity Building
9
Annual Report MEDBOX
1
Toolboxes
AMR
159
Pharmacy
130
COVID-19
72
TB
57
HIV
51
Mental Health
46
Planetary Health
38
NTDs
34
Rapid Response
28
Global Health Education
26
Conflict
22
NCDs
22
Caregiver
20
Health Financing Toolbox
19
Ebola & Marburg
17
2.0 Rapid Response
15
Malaria
13
Disability
9
Refugee
7
Specific Hazards
6
Polio
5
Natural Hazards
5
Zika
3
Experience of national TB partnerships
17–24 November 2015
September 2014
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicable and Noncommunicable Diseases, welcomed participan
...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a
...
This new edition and fully updated publication replaces the 2012 UCG and is being circulated free of charge to all public and private sector prescribers, pharmacists, and regulatory authorities in the country
Framework for implementation.
The END TB Strategy.
Therapeutics Information and Pharmacovigilance Centre | TIPC
This document highlights the key aspects of safe health-care waste management in order to guide policy-makers, practitioners and facility managers to improve such services in health-care facilities. It is based on the comprehensive WHO handbook Safe management of wastes from health-care activities (
...
Mission report: June 11-20, 2017
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of use, the man
...
The evolving epidemic of type 2 diabetes mellitus has challenged health-care professionals. It stands among the leading causes of mortality in the present world. It warrants new and versatile approaches to improve mortality and the associated huge quality-adjusted life years lost to it once diagnose
...
Cervical intraepithelial neoplasia (CIN) is a premalignant lesion that may exist at any one of three stages: CIN1, CIN2, or CIN3. If left untreated, CIN2 or CIN3 (collectively referred to as CIN2+) can progress to cervical cancer. Instead of screening and diagnosis by the standard sequence of cytolo
...
This short guide to the Global Diabetes Compact explains what diabetes is and why action to improve prevention efforts, diagnosis and treatment is so urgent. It outlines the key asks associated with the Compact and emphasizes that increasing access to insulin, strengthening health systems and meanin
...
Accessed November, 2017
